Results 131 to 140 of about 160,647 (335)

Hepatotoxicity

Folia Pharmacologica Japonica, 2008
Munehiro, Teranishi, Sunao, Manabe
openaire   +3 more sources

Potential Protective Effects of Propolis against Hepatotoxicity and Nephrotoxicity Induced by Monosodium Glutamate in Rabbits [PDF]

, 2019
Mokhtar I. Yousef, Doaa El-Nassag, Mahmoud Gasser, Alaa Ibrahim   +3 more
openalex   +1 more source

Bioinformatics‐based discovery of the involvement of PSAT1 in mediating the anti‐lung adenocarcinoma activity of triptolide

Animal Models and Experimental Medicine, EarlyView.
Transcriptome sequencing was performed on tumor tissues from triptolide‐treated tumor‐bearing mice. The sequencing results were integrated with data from public databases for comprehensive analysis, and potential regulatory targets of triptolide were identified.
Zhiwen Cao, Lulu Zhang, Wenqiang Zhang, Rong Wan, Xiaogang Peng, Jinyan Xie, Ruru Bai, Jiejing Jin, Changqi Shi, Lan Yan, Xiangyu Guo, Yang Shen, Cheng Lu   +12 more
wiley   +1 more source

The Influence of Safety, Efficacy, and Medical Condition Severity on Natural v. Synthetic Drug Preference

, 2016
Research indicates that there is a preference for natural v. synthetic products, but the influence of this preference on drug choice in the medical domain is largely unknown.
Lappas, Courtney M., Meier, Brian P.
core   +1 more source

Evaluate the efficacy of Darvyadi lauha(A herbo mineral compound) in the management of hepatocellular jaundice(Kamala) and hepato-protective activity in paracetamol induced hepatotoxicity- A randomised controlled clinical [PDF]

, 2021
P S Arshathjyothi
openalex  

Advances and Challenges in Micro/Nanocarrier‐Based Dermal Drug Delivery Systems for Acne Treatment

Advanced NanoBiomed Research, EarlyView.
Topical acne treatment faces challenges from skin barriers and complex causes. Micro/nanocarriers improve drug delivery by enhancing bioavailability, targeting, and duration. Combining carriers creates synergistic effects for systematic intervention.
Jintao Yang, Jie Chen, Yunmiao Ma, Qingwei Zhou, Yu Kong, Yingxiang Chen, Junjie Chi, Haihua Hu   +7 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Effects of <i>Euphorbia thymifolia</i> and <i>Euphorbia hirta</i> leaf extracts on membrane-bound, mitochondrial enzymes and lipid profile of carbon tetrachloride-induced hepatotoxicity in rats [PDF]

, 2022
Gurupalraj Durai Muthu Mani, Balamuralikrishnan Balasubramanian, Ramasamy Manikandan, P. Sampathkumar, Arun Meyyazhagan, Rengasamy R Lakshminarayanan, Wen‐Chao Liu, Arumugam Vijaya Anand   +7 more
openalex   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Lactobacillus rhamnosus GG ameliorates triptolide-induced liver injury through modulation of the bile acid-FXR axis

Pharmacological Research
Triptolide (TP) is the principal bioactive compound of Tripterygium wilfordii with significant anti-tumor, anti-inflammatory and immunosuppressive activities. However, its severe hepatotoxicity greatly limits its clinical use. The underlying mechanism of
Shiping Hu, Bo Tang, Cheng Lu, Sumin Wang, Lingyi Wu, Yuanyuan Lei, Li Tang, Hongbin Zhu, Dongxu Wang, Shiming Yang   +9 more
doaj   +1 more source